지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2020.1
- 수록면
- 1 - 12 (12page)
이용수
초록· 키워드
오류제보하기
Endothelial-to-mesenchymal transition (EndMT) involves the phenotypic conversion of endothelial-to-mesenchymal cells, and was first discovered in association with embryonic heart development. EndMT can regulate various processes, such as tissue fibrosis and cancer. Recent findings have shown that EndMT is related to resistance to cancer therapy, such as chemotherapy, antiangiogenic therapy, and radiation therapy. Based on the known effects of EndMT on the cardiac toxicity of anticancer therapy and tissue damage of radiation therapy, we propose that EndMT can be targeted as a strategy for overcoming tumor resistance while reducing complications, such as tissue damage. In this review, we discuss EndMT and its roles in damaging cardiac and lung tissues, as well as EndMT-related effects on tumor vasculature and resistance in anticancer therapy. Modulating EndMT in radioresistant tumors and radiationinduced tissue fibrosis can especially increase the efficacy of radiation therapy. In addition, we review the role of hypoxia and reactive oxygen species as the main stimulating factors of tissue damage due to vascular damage and EndMT. We consider drugs that may be clinically useful for regulating EndMT in various diseases. Finally, we argue the importance of EndMT as a therapeutic target in anticancer therapy for reducing tissue damage.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Endothelial-specific deletion of Ets-1 attenuates Angiotensin II-induced cardiac fibrosis via suppression of endothelial-to-mesenchymal transition
BMB Reports
2019 .01
-
Single-cell sequencing reveals that endothelial cells, EndMT cells and mural cells contribute to the pathogenesis of cavernous malformations
Experimental and Molecular Medicine
2023 .03
-
BMP-4 treatment for EndMT in plastic HUVEC resulting increased osteogenic differentiation capability
한국생물공학회 학술대회
2016 .04
-
Molecular targeted therapy for anticancer treatment
Experimental and Molecular Medicine
2022 .10
-
Gene Therapy for Bone Tissue Engineering
조직공학과 재생의학
2016 .01
-
Upconversion Nanoparticles for Deep Tissue Cancer Therapy and Imaging
한국고분자학회 학술대회 연구논문 초록집
2015 .10
-
Remodeling and Restraining Lung Tissue Damage Through the Regulation of Respiratory Immune Responses
조직공학과 재생의학
2023 .06
-
Tumor microenvironment and radioresistance
Experimental and Molecular Medicine
2021 .06
-
Vision-based Identification of Soft Tissues with Different Stiffness
대한기계학회 춘추학술대회
2021 .04
-
Human Adipose Tissue Derivatives as a Potent Native Biomaterial for Tissue Regenerative Therapies
조직공학과 재생의학
2020 .01
-
Nanoparticles for Targeted Cancer Therapy
한국고분자학회 학술대회 연구논문 초록집
2016 .10
-
Combination of Chemotherapy and Sonodynamic Therapy with Polylactide-poly (ethylene glycol) Polymersomes for Effective Cancer Treatments
한국생물공학회 학술대회
2021 .10
-
The Use of Normal Stem Cells and Cancer Stem Cells for Potential Anti-Cancer Therapeutic Strategy
조직공학과 재생의학
2018 .01
-
Stem Cell-based Gene Therapy for Solid Tumors and Chronic Diseases
한국생물공학회 학술대회
2023 .10
-
심근유래의 줄기세포 프라이밍 및 조직공학 기술에 의한 심혈관 재생 전략
KSBB Journal
2018 .09
-
Oral Tissue Engineering Progress and Challenges
조직공학과 재생의학
2015 .01
-
암치료 연구를 위한 광이미징분석용 생체모사플렛폼 가공 및 활용
한국정밀공학회 학술발표대회 논문집
2016 .05
-
Tailoring Functional Nanomaterials for Efficient Gene Therapy and Tissue Regeneration
한국고분자학회 학술대회 연구논문 초록집
2024 .09
-
In Vivo Observation of Endothelial Cell-Assisted Vascularization in Pancreatic Cancer Xenograft Engineering
조직공학과 재생의학
2018 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0